JP2022527630A5 - - Google Patents
Info
- Publication number
- JP2022527630A5 JP2022527630A5 JP2021560228A JP2021560228A JP2022527630A5 JP 2022527630 A5 JP2022527630 A5 JP 2022527630A5 JP 2021560228 A JP2021560228 A JP 2021560228A JP 2021560228 A JP2021560228 A JP 2021560228A JP 2022527630 A5 JP2022527630 A5 JP 2022527630A5
- Authority
- JP
- Japan
- Prior art keywords
- approximately
- pharmaceutical composition
- composition according
- sucralose
- citric acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962829784P | 2019-04-05 | 2019-04-05 | |
| US62/829,784 | 2019-04-05 | ||
| PCT/US2020/026696 WO2020206336A1 (en) | 2019-04-05 | 2020-04-03 | Pde9 inhibitors for treating sickle cell disease |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022527630A JP2022527630A (ja) | 2022-06-02 |
| JP2022527630A5 true JP2022527630A5 (cg-RX-API-DMAC7.html) | 2023-04-10 |
Family
ID=72666968
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021560228A Pending JP2022527630A (ja) | 2019-04-05 | 2020-04-03 | 鎌状赤血球症を治療するためのpde9阻害剤 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20220023302A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP3946348A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2022527630A (cg-RX-API-DMAC7.html) |
| CN (1) | CN114302724A (cg-RX-API-DMAC7.html) |
| BR (1) | BR112021019876A2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3136128A1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL286976A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2020206336A1 (cg-RX-API-DMAC7.html) |
| ZA (1) | ZA202107544B (cg-RX-API-DMAC7.html) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2990521C (en) | 2015-07-07 | 2023-10-10 | H. Lundbeck A/S | Pde9 inhibitors with imidazo triazinone backbone and imidazo pyrazinone backbone for treatment of peripheral diseases |
| BR112020024019A2 (pt) | 2018-05-25 | 2021-02-23 | Imara Inc. | monoidrato e formas cristalinas de 6-[(3s,4s)-4-metil-1-(pirimidin-2-ilmetil)pirrolidin-3-il]-3-tetra-hidropiran-4-il-7h-imidazo[1,5-a]pirazin-8-ona |
| KR20250108770A (ko) | 2018-08-31 | 2025-07-15 | 카듀리온 파마슈티칼스, 인크. | 겸상 세포 질환의 치료를 위한 pde9 억제제 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1928237A4 (en) * | 2005-09-02 | 2011-03-09 | Abbott Lab | NEW HETEROCYCLES BASED ON IMIDAZO |
| JP4941977B2 (ja) * | 2007-04-11 | 2012-05-30 | 大蔵製薬株式会社 | ベンズイソキサゾール誘導体の経口ゼリー状医薬組成物 |
| MX381326B (es) * | 2011-10-10 | 2025-03-12 | H Lundbeck As | Derivados de 7h-imidazo[1-5-a]pirazin-8-ona como inhibidores de la fosfodiesterasa 9(pde9); y el uso de los mismos en el tratamiento de trastornos neurodegenerativos |
| JP5341282B1 (ja) * | 2012-06-29 | 2013-11-13 | 丸石製薬株式会社 | アリピプラゾールの経口医薬製剤 |
| CA2990521C (en) * | 2015-07-07 | 2023-10-10 | H. Lundbeck A/S | Pde9 inhibitors with imidazo triazinone backbone and imidazo pyrazinone backbone for treatment of peripheral diseases |
| UA125025C2 (uk) * | 2016-04-04 | 2021-12-29 | Локсо Онколоджі, Інк. | Способи лікування дитячих ракових захворювань |
| IL295973A (en) * | 2016-07-06 | 2022-10-01 | H Lundbeck As | pde9 inhibitors for the treatment of peripheral diseases |
| HUE065158T2 (hu) * | 2017-05-26 | 2024-05-28 | Cardurion Pharmaceuticals Inc | PDE9 gátlószereinek elõállítására és alkalmazására szolgáló eljárások |
| CN114072151A (zh) * | 2019-05-07 | 2022-02-18 | 伊马拉公司 | 用于治疗地中海贫血的pde9抑制剂 |
-
2020
- 2020-04-03 WO PCT/US2020/026696 patent/WO2020206336A1/en not_active Ceased
- 2020-04-03 CN CN202080041606.3A patent/CN114302724A/zh active Pending
- 2020-04-03 CA CA3136128A patent/CA3136128A1/en active Pending
- 2020-04-03 BR BR112021019876A patent/BR112021019876A2/pt not_active Application Discontinuation
- 2020-04-03 JP JP2021560228A patent/JP2022527630A/ja active Pending
- 2020-04-03 EP EP20783704.8A patent/EP3946348A4/en not_active Withdrawn
-
2021
- 2021-10-04 US US17/493,677 patent/US20220023302A1/en not_active Abandoned
- 2021-10-04 IL IL286976A patent/IL286976A/en unknown
- 2021-10-07 ZA ZA2021/07544A patent/ZA202107544B/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2025142338A5 (cg-RX-API-DMAC7.html) | ||
| CN101171005A (zh) | Pde4抑制剂罗氟司特与四氢生物蝶呤衍生物的组合 | |
| ES2259098T3 (es) | Composiciones que comprenden ipatropio y xilometazolina para el tratamiento del resfriado comun. | |
| KR100841893B1 (ko) | 프레가발린 조성물 | |
| US20080132517A1 (en) | Method of enhancing absorptions of transmucosal administration formulations | |
| CA2782734C (en) | Nicotine containing formulation | |
| CN111683683A (zh) | Pde v抑制剂的液体口服制剂 | |
| CN102470099A (zh) | 儿童用奥洛他定鼻腔喷雾方案 | |
| ES2791775A2 (es) | Formulaciones de epinefrina intranasal y metodos para el tratamiento de enfermedades | |
| JP2024510287A (ja) | L-セリン又はその薬学的に許容される塩の液体製剤及びそれを調製するための方法 | |
| JPH07505645A (ja) | 医薬組成物 | |
| ES2239802T3 (es) | Composiciones farmaceuticas. | |
| JP5314014B2 (ja) | テルビブジンを含む医薬内用液 | |
| JP2022536669A5 (cg-RX-API-DMAC7.html) | ||
| TWI327913B (en) | Pharmaceutical composition comprising 5-methyl-2-(2'-chloro-6'-fluoroanilino)phenylacetic acid | |
| JP2007269786A (ja) | パンテチン含有経口液剤 | |
| CN105213402A (zh) | 一种畜禽复方恩诺沙星美洛昔康可溶性粉 | |
| PT1482938E (pt) | Composição farmacêutica de um inibidor da pde4 ou de um inibidor da pde3/4 e um antagonista dos receptores histamínicos | |
| WO2011093831A2 (en) | Effervescent formulations comprising cefprozil as active agent | |
| CN121285367A (zh) | 包含布洛芬的药物组合物 | |
| ES2629103T3 (es) | Formulación en polvo de valganciclovir | |
| WO2018053423A1 (en) | Pharmaceutical composition of ibuprofen sodium for oral administration | |
| JP2003512421A5 (cg-RX-API-DMAC7.html) | ||
| JP2006528160A (ja) | 抗血栓性化合物の口腔分散性医薬組成物 | |
| JPH11139970A (ja) | 経口液剤 |